SOLTA MEDICAL INC 4
4 · SOLTA MEDICAL INC · Filed Jan 27, 2014
Insider Transaction Report
Form 4
STANG ERIC B
Director
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$1.43/sh−50,000$71,500→ 0 totalExercise: $1.49Exp: 2018-12-23→ Common Stock (50,000 underlying) - Disposition from Tender
Common Stock
2014-01-23$2.92/sh−31,627$92,351→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$0.45/sh−25,000$11,250→ 0 totalExercise: $2.47Exp: 2020-06-03→ Common Stock (25,000 underlying) - Disposition from Tender
Common Stock
2014-01-23$2.92/sh−48,097$140,443→ 0 total(indirect: By Trust)
Footnotes (3)
- [F1]Deemed acquired pursuant to the grant of restricted stock units on June 5, 2013 ("RSU's"). The vesting of the RSU's was accelerated in connection with the merger of the Issuer with Valeant Pharmaceuticals International, a Delaware corporation (the "Merger").
- [F2]Shares held directly by the Stang Family Trust dated September 2, 2004 (the "Trust"), of which the Reporting Person and Pamela R. Stang are co-trustees.
- [F3]This option, which had become fully vested and exercisable, was cancelled at the closing of the Merger in exchange for a cash payment equal to the product of (a) the number of shares underlying this option and (b) the difference between the merger consideration of $2.92 per share and the exercise price per share of this option.